Axon Enterprise, Inc (NASDAQ:AXON – Get Free Report) CEO Patrick Smith sold 10,000 shares of the business’s stock in a transaction on Monday, June 29th. The stock was sold at an average price of $500.00, for a total transaction of $5,000,000.00. Following the completion of the sale, the chief executive officer directly owned 3,050,997 shares in the company, valued at approximately $1,525,498,500. This represents a 0.33% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Axon Enterprise Stock Up 9.8%
Axon Enterprise stock traded up $50.01 during mid-day trading on Tuesday, reaching $560.61. The company’s stock had a trading volume of 1,562,938 shares, compared to its average volume of 1,102,856. The company has a market capitalization of $45.19 billion, a price-to-earnings ratio of 225.14, a price-to-earnings-growth ratio of 9.48 and a beta of 1.45. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $885.91. The business’s 50 day simple moving average is $423.00 and its 200 day simple moving average is $481.32. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.93 and a current ratio of 2.27.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.01. Axon Enterprise had a net margin of 6.90% and a return on equity of 3.78%. The firm had revenue of $807.35 million for the quarter, compared to analyst estimates of $778.90 million. During the same period in the previous year, the business earned $1.47 EPS. The company’s revenue was up 33.7% compared to the same quarter last year. As a group, research analysts anticipate that Axon Enterprise, Inc will post 1.63 earnings per share for the current year.
Institutional Inflows and Outflows
Analyst Ratings Changes
Several analysts recently issued reports on AXON shares. UBS Group dropped their target price on Axon Enterprise from $570.00 to $440.00 and set a “neutral” rating on the stock in a report on Thursday, May 7th. Piper Sandler restated an “overweight” rating and issued a $674.00 price target on shares of Axon Enterprise in a research note on Monday, June 15th. TD Cowen lowered their price target on Axon Enterprise from $950.00 to $825.00 and set a “buy” rating on the stock in a research report on Wednesday, April 8th. Zacks Research upgraded Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 19th. Finally, JPMorgan Chase & Co. upped their price objective on Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. One investment analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $712.75.
Get Our Latest Stock Report on AXON
Key Axon Enterprise News
Here are the key news stories impacting Axon Enterprise this week:
- Positive Sentiment: Reports that President Trump bought up to $5 million of Axon stock before ICE later posted a notice for a possible $220 million Taser deal have fueled speculation that Axon could benefit from a large government order. Trump bought as much as $5 million in Axon stock before ICE sought $220 million Taser deal
- Positive Sentiment: Several market recaps say Axon’s move is being driven by the Trump/ICE news, which has put the stock back in the spotlight and helped extend momentum. Why Is Axon Enterprise Stock Surging On Tuesday?
- Positive Sentiment: Northland Securities reiterated its Buy rating on Axon Enterprise, reinforcing a bullish analyst view on the company’s long-term growth prospects. Northland Securities Reaffirms Their Buy Rating on Axon Enterprise (AXON)
- Neutral Sentiment: CEO commentary highlighting Axon’s mission to reduce gun violence and expand nonlethal public safety tools may support the company’s growth narrative, but it is not a direct catalyst by itself. CEO of Taser maker Axon: We are moving closer to making bullets extinct
- Negative Sentiment: The Trump-ICE timing has also raised conflict-of-interest and ethics questions, creating headline risk that could weigh on Axon if political scrutiny intensifies. Axon Enterprise (AXON) Stock Drew Ethics Questions After Trump Bought $5 Million In Shares
Axon Enterprise Company Profile
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
See Also
- Five stocks we like better than Axon Enterprise
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
